ABVC BioPharma, Inc. – NASDAQ:ABVC
ABVC BioPharma stock price today
ABVC BioPharma stock price monthly change
ABVC BioPharma stock price quarterly change
ABVC BioPharma stock price yearly change
ABVC BioPharma key metrics
Market Cap | 6.56M |
Enterprise value | 23.49M |
P/E | -1.17 |
EV/Sales | 68.48 |
EV/EBITDA | -1.27 |
Price/Sales | 59.83 |
Price/Book | 6.62 |
PEG ratio | 0.59 |
EPS | -2.29 |
Revenue | 25.36K |
EBITDA | -9.60M |
Income | -12.62M |
Revenue Q/Q | -99.06% |
Revenue Y/Y | -97.63% |
Profit margin | -5682.74% |
Oper. margin | -5372.83% |
Gross margin | 93.06% |
EBIT margin | -5372.83% |
EBITDA margin | -37884.09% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeABVC BioPharma stock price history
ABVC BioPharma stock forecast
ABVC BioPharma financial statements
| Jun 2023 | 6.10K | -2.26M | -37052.07% |
|---|---|---|---|
| Sep 2023 | 15.88K | -3.31M | -20885.9% |
| Dec 2023 | 2.16K | -3.11M | -143692.1% |
| Mar 2024 | 1.20K | -3.93M | -326388.05% |
| 2025 | 4.17M | -19.94M | -477.93% |
|---|---|---|---|
| 2026 | 35.28M | 5.63M | 15.97% |
Analysts Price target
Financials & Ratios estimates
| 2023-03-29 | -0.15 | -0.31 |
|---|---|---|
| 2023-05-15 | -0.15 | -0.15 |
| Jun 2023 | 9320407 | 9.68M | 103.94% |
|---|---|---|---|
| Sep 2023 | 16591507 | 7.52M | 45.38% |
| Dec 2023 | 14944079 | 6.36M | 42.57% |
| Mar 2024 | 14686142 | 6.97M | 47.48% |
| Jun 2023 | -899.82K | -440.57K | -31.58K |
|---|---|---|---|
| Sep 2023 | -1.35M | -73.78K | 1.65M |
| Dec 2023 | -461.99K | 154.17K | 87.42K |
| Mar 2024 | -602.00K | 0 | 805.00K |
ABVC BioPharma alternative data
| Aug 2023 | 19 |
|---|---|
| Sep 2023 | 19 |
| Oct 2023 | 19 |
| Nov 2023 | 19 |
| Dec 2023 | 19 |
| Jan 2024 | 19 |
| Feb 2024 | 19 |
| Mar 2024 | 16 |
| Apr 2024 | 16 |
| May 2024 | 16 |
| Jun 2024 | 16 |
| Jul 2024 | 16 |
ABVC BioPharma other data
| Period | Buy | Sel |
|---|---|---|
| Jun 2009 | 115 | 0 |
| Aug 2009 | 384616 | 0 |
| Oct 2009 | 14640 | 0 |
| Nov 2009 | 714286 | 0 |
| Dec 2009 | 31 | 0 |
| Jan 2010 | 55 | 0 |
| Mar 2010 | 2000 | 0 |
| May 2010 | 10000 | 0 |
| Insider | Compensation |
|---|---|
Dr. Tsung-Shann Jiang Ph.D. (1954) Chief Strategy Officer, Member of Scientific Advisory Board & Director | $200,000 |
Dr. Chi-Hsin King (1948) Chief Scientific Officer | $200,000 |
Mr. Chihliang An (1982) Chief Financial Officer | $200,000 |
Dr. Howard Doong M.D., Ph.D. (1957) Pres & Chief Executive Officer | $200,000 |
Mr. Eugene Jiang (1986) Chairman & Chief Bus. Officer | $200,000 |
-
What's the price of ABVC BioPharma stock today?
One share of ABVC BioPharma stock can currently be purchased for approximately $2.91.
-
When is ABVC BioPharma's next earnings date?
Unfortunately, ABVC BioPharma's (ABVC) next earnings date is currently unknown.
-
Does ABVC BioPharma pay dividends?
No, ABVC BioPharma does not pay dividends.
-
How much money does ABVC BioPharma make?
ABVC BioPharma has a market capitalization of 6.56M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 84.28% to 152.43K US dollars. ABVC BioPharma made a loss 10.52M US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.
-
What is ABVC BioPharma's stock symbol?
ABVC BioPharma, Inc. is traded on the NASDAQ under the ticker symbol "ABVC".
-
What is ABVC BioPharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of ABVC BioPharma?
Shares of ABVC BioPharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are ABVC BioPharma's key executives?
ABVC BioPharma's management team includes the following people:
- Dr. Tsung-Shann Jiang Ph.D. Chief Strategy Officer, Member of Scientific Advisory Board & Director(age: 71, pay: $200,000)
- Dr. Chi-Hsin King Chief Scientific Officer(age: 77, pay: $200,000)
- Mr. Chihliang An Chief Financial Officer(age: 43, pay: $200,000)
- Dr. Howard Doong M.D., Ph.D. Pres & Chief Executive Officer(age: 68, pay: $200,000)
- Mr. Eugene Jiang Chairman & Chief Bus. Officer(age: 39, pay: $200,000)
-
How many employees does ABVC BioPharma have?
As Jul 2024, ABVC BioPharma employs 16 workers.
-
When ABVC BioPharma went public?
ABVC BioPharma, Inc. is publicly traded company for more then 20 years since IPO on 10 Nov 2004.
-
What is ABVC BioPharma's official website?
The official website for ABVC BioPharma is abvcpharma.com.
-
Where are ABVC BioPharma's headquarters?
ABVC BioPharma is headquartered at 44370 Old Warm Springs Boulevard, Fremont, CA.
-
How can i contact ABVC BioPharma?
ABVC BioPharma's mailing address is 44370 Old Warm Springs Boulevard, Fremont, CA and company can be reached via phone at +51 06680881.
ABVC BioPharma company profile:
ABVC BioPharma, Inc.
abvcpharma.comNASDAQ
16
Biotechnology
Healthcare
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity disorder; ABV-1703 has completed Phase I clinical trials for the treatment of pancreatic cancer; ABV-1702 has completed Phase I clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.
Fremont, CA 94538
CIK: 0001173313
ISIN: US00091F3047
CUSIP: 00091F106
